|
Volumn 47, Issue 3, 2012, Pages 467-468
|
Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FOLLITROPIN;
GRANULOCYTE COLONY STIMULATING FACTOR;
LUTEINIZING HORMONE;
TESTOSTERONE;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
BLOOD ANALYSIS;
CLINICAL EFFECTIVENESS;
DISEASE ASSOCIATION;
DISEASE DURATION;
DOSE RESPONSE;
DRUG MEGADOSE;
FOLLITROPIN BLOOD LEVEL;
GRAFT FAILURE;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RELEASE;
LETTER;
LUTEINIZING HORMONE BLOOD LEVEL;
PRIORITY JOURNAL;
SEMEN ANALYSIS;
SPERMATOZOON COUNT;
SPERMATOZOON MOTILITY;
TESTIS FUNCTION;
TESTOSTERONE BLOOD LEVEL;
ADOLESCENT;
ADULT;
AREA UNDER CURVE;
CHILD;
CYCLOPHOSPHAMIDE;
DIABETES MELLITUS, TYPE 1;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
RETROSPECTIVE STUDIES;
TESTIS;
TIME FACTORS;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 84858070743
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2011.113 Document Type: Letter |
Times cited : (9)
|
References (10)
|